Chief Scientific Officer
Current
Dec 2024 - Present
AeroLeads people directory · profile
Peter Olson Email & Phone Number
CSO at Iambic Therapeutics
at
Iambic Therapeutics
2 work emails found
@mirati.com
4 phones found area 858
LinkedIn matched
✓ Verified Jul 2026
4 data sources
Profile completeness 100%
Current company
Role
CSO at Iambic Therapeutics
Location
San Diego, California, United States
Who is Peter Olson? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Peter Olson is listed as CSO at Iambic Therapeutics at Iambic Therapeutics, based in San Diego, California, United States. AeroLeads shows a work email signal at mirati.com, phone signal with area code 858, and a matched LinkedIn profile for Peter Olson.
Peter Olson previously worked as Chief Scientific Officer at Iambic Therapeutics and Vice President, Research at Bristol Myers Squibb. Peter Olson holds Phd, Biology from Uc San Diego.
Company email context
Email format at Iambic Therapeutics
This section adds company-level context without repeating Peter Olson's masked contact details.
{last}{first_initial}@mirati.com
89% confidence
AeroLeads found 2 current-domain work email signals for Peter Olson. Compare company email patterns before reaching out.
Profile bio
About Peter Olson
Pete Olson, PhD, is the Chief Scientific Officer at Iambic Therapeutics, a clinical-stage biotechnology company accelerating drug discovery by leveraging AI models for protein structure prediction and wholistic drug design with high-throughput chemistry and biology experimentation. Prior to Iambic, he was most recently VP, Research at Mirati Therapeutics, which was acquired by Bristol Myers Squibb in Jan, 2024. Here he built a successful track record running in vitro and in vivo biology / pharmacology functions to drive small molecule oncology programs from target identification to clinical proof-of-concept. He has deep experience targeting oncogenic driver and synthetic lethal cancer pathways and developing robust pre-clinical data packages that generate clinically-testable precision medicine hypotheses. During his tenure, several programs reached the clinic including adagrasib (KRAS G12C inhibitor; FDA approved; KRAZATI), BMS-986504 (previously MRTX1719; MTA-cooperative PRMT5 inhibitor for the treatment of MTAP-deleted cancers), MRTX1133 (KRAS G12D inhibitor), MRTX0902 (SOS1 inhibitor) and ORIC-944 (EED (PRC2) inhibitor out licensed to ORIC Pharmaceuticals). Prior to Mirati, Pete was a Senior Group Leader in the Pfizer Oncology Research Unit where he led projects including translational research for the Gamma Secretase Inhibitor (GSI) program out licensed to SpringWorks Therapeutics (nirogacestat; OGSIVEO; FDA approved). He has over 25 years of basic, pre-clinical and translational research experience across academia and industry.
Listed skills include In Vivo, Drug Discovery, In Vitro, Translational Research, and 19 others.
Current workplace
Peter Olson's current company
Company context helps verify the profile and gives searchers a useful next step.
12 roles · 29 years
Peter Olson work experience
A career timeline built from the work history available for this profile.
Vice President, Research
Jan 2024 - Dec 2024
Vice President, Research
*Directed in vitro and in vivo drug discovery pharmacology and translational research lab*Led biology-side drug discovery projects from target validation to Phase I*Oversaw highly productive translational team that used genetic and pharmacologic strategies to elucidate drug MOA, identify clinically-tractable biomarkers of intrinsic and acquired resistance, and identify efficacious combinations*Led clinical translational sciences for multiple clinical-stage programs with oncogenic driver, synthetic lethal and immune-based mechanisms of action
Jan 2024 - Jan 2024
Executive Director Of Research
Jan 2022 - Jan 2024
Senior Director Of Research
May 2019 - Jan 2022
Director Of Research
Oct 2015 - May 2019
Senior Principal Scientist
*Directed translational research for clinical program. Responsible for generating patient selection hypotheses, identification of clinically useful biomarkers, elucidating mechanisms of resistance to targeted therapies and identifying more efficacious and durable combination strategies.*Research Project Lead for a drug discovery oncology program. Responsible for the biology of the program on a multi-disciplinary team including identification of cell based biomarkers, understanding mechanism of action, identifying patient populations of interest and program strategy.*Target identification / validation. Using a variety of bioinformatics and functional approaches to validate new target hypotheses and find the next generation of cancer drugs.
Sep 2014 - Oct 2015
Principal Scientist
*Directed translational research for clinical programs*Research Project Lead for drug discovery program*Led in vivo pharmacology lab*Led target identification / validation lab
Oct 2009 - Sep 2014
Postdoc
Laboratory of Douglas HanahanStudied microRNAs in cancer, angiogenesis, pancreatic cancer, patient segmentation and differential response to therapy, cancer genetics
Apr 2005 - Oct 2009
Graduate Student
Laboratory of Ronald EvansStudied the role of the nuclear fatty acid receptors PPARg and PPARd in metabolic disease and cancer
1998 - 2005
~7 yrs
Research Associate
Explored the utility of chemically modified antisense oligonucleotides for the treatment of cancer
Jun 1996 - Aug 1998
Jun 1995 - Aug 1995
2 education records
Peter Olson education
Phd, Biology
Uc San Diego
Bs, Biochemistry
University Of California, Davis
FAQ
Frequently asked questions about Peter Olson
Quick answers generated from the profile data available on this page.
What company does Peter Olson work for?
Peter Olson works for Iambic Therapeutics.
What is Peter Olson's role at Iambic Therapeutics?
Peter Olson is listed as CSO at Iambic Therapeutics at Iambic Therapeutics.
What is Peter Olson's email address?
AeroLeads has found 2 work email signals at @mirati.com for Peter Olson at Iambic Therapeutics.
What is Peter Olson's phone number?
AeroLeads has found 4 phone signal(s) with area code 858 for Peter Olson at Iambic Therapeutics.
Where is Peter Olson based?
Peter Olson is based in San Diego, California, United States while working with Iambic Therapeutics.
What companies has Peter Olson worked for?
Peter Olson has worked for Iambic Therapeutics, Bristol Myers Squibb, Mirati Therapeutics, Pfizer, and Ucsf.
How can I contact Peter Olson?
You can use AeroLeads to view verified contact signals for Peter Olson at Iambic Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Peter Olson attend?
Peter Olson holds Phd, Biology from Uc San Diego.
What skills is Peter Olson known for?
Peter Olson is listed with skills including In Vivo, Drug Discovery, In Vitro, Translational Research, Oncology, Signal Transduction, Assay Development, and Cancer.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial